Genmab Overview
Genmab Target Price
Analysts' 12-month price predictions for GMAB.
Get informed when a big investor buys or sells
+ FollowShare Price
$25.08
Average Target Price
$38.30
52.7% upside
52.7% upside5 analysts in the last 4 months
High: $41.5 | Low: $32
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-27 | Truist FinancialGregory Renza | $40 | 59.5% upside |  |
| 2026-04-30 | H.C. Wainwright | $38 | 51.5% upside | |
| 2026-03-26 | Wolfe Research | $32 | 27.6% upside | |
| 2026-02-23 | GuggenheimMichael Schmidt | $40 | 59.5% upside | |
| 2026-02-17 | JefferiesBenjamin Jackson | $41.5 | 65.5% upside | |
| 2026-01-20 | H.C. Wainwright | $39 | 55.5% upside | |
| 2025-11-06 | Truist FinancialAsthika Goonewardene | $48 | 91.4% upside | |
| 2025-10-06 | Truist FinancialAsthika Goonewardene | $49 | 95.4% upside | |
| 2025-10-02 | H.C. Wainwright | $40 | 59.5% upside | |
| 2025-09-29 | Leerink PartnersJonathan Chang | $34 | 35.6% upside | |
| 2025-09-23 | GuggenheimMichael Schmidt | $43 | 71.5% upside | |
| 2025-03-11 | Truist FinancialAsthika Goonewardene | $45 | 79.4% upside | |
| 2024-09-04 | Morgan StanleyVikram Purohit | $31 | 23.6% upside | |
| 2024-08-09 | BMO CapitalEtzer Darout | $46 | 83.4% upside | |
| 2024-06-27 | BTIGKaveri Pohlman | $47 | 87.4% upside | |
| 2024-06-27 | H.C. WainwrightRaghuram Selvaraju | $50 | 99.4% upside | |
| 2024-06-04 | Truist FinancialAsthika Goonewardene | $53 | 111.3% upside | |
| 2024-02-23 | BMO CapitalEtzer Darout | $48 | 91.4% upside | |
| 2023-02-06 | Leerink Partners | $36 | 43.5% upside | |
| 2022-11-28 | Morgan StanleyMatthew Harrison | $34 | 35.6% upside | |
| 2022-05-02 | Cowen & Co. | $38 | 51.5% upside | |